Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Influenza antiviral use for persons at high risk for influenza complications or who have severe influenza illness
  • Published Date:
    2/29/08
  • Series:
    HAN ; 271
  • Language:
    English
Filetype[PDF-47.83 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
    Personal Author:
    Lo, Michael K.; Albariño, César G.; Perry, Jason K.; Chang, Silvia; Tchesnokov, Egor P.; Guerrero, Lisa; Chakrabarti, Ayan; Shrivastava-Ranjan, Punya; Chatterjee, Payel; McMullan, Laura K.; Martin, Ross; Jordan, Robert; Götte, Matthias; Montgomery, Joel M.; Nichol, Stuart T.; Flint, Mike; Porter, Danielle; Spiropoulou, Christina F.;
    Published Date:
    October 07 2020
    Source:
    Proc Natl Acad Sci U S A. 2020; 117(43):26946-26954
    Description:
    Remdesivir is a broad-spectrum antiviral nucleotide prodrug that has been clinically evaluated in Ebola virus patients and recently received emergency use authorization (EUA) for treatment of COVID-19. With approvals from the Federal Select Agent Pro...
    File Type:
    Filetype[PDF - 1.45 MB]
  2. Abdominal Visceral Infarction in 3 Patients with COVID-19
    Personal Author:
    Besutti, Giulia; Bonacini, Riccardo; Iotti, Valentina; Marini, Giulia; Riva, Nicoletta; Dolci, Giovanni; Maiorana, Mariarosa; Spaggiari, Lucia; Monelli, Filippo; Ligabue, Guido; Guaraldi, Giovanni; Rossi, Paolo Giorgi; Pattacini, Pierpaolo; Massari, Marco;
    Published Date:
    May 12 2020
    Source:
    Emerg Infect Dis. 26(8):1926-1928
    Description:
    A high incidence of thrombotic events has been reported in patients with coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We report 3 clinical cases of patients in Italy with C...
    File Type:
    Filetype[PDF - 531.57 KB]
  3. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
    Personal Author:
    Sheahan, Timothy P.; Sims, Amy C.; Zhou, Shuntai; Graham, Rachel L.; Pruijssers, Andrea J.; Agostini, Maria L.; Leist, Sarah R.; Schäfer, Alexandra; Dinnon, Kenneth H.; Stevens, Laura J.; Chappell, James D.; Lu, Xiaotao; Hughes, Tia M.; George, Amelia S.; Hill, Collin S.; Montgomery, Stephanie A.; Brown, Ariane J.; Bluemling, Gregory R.; Natchus, Michael G.; Saindane, Manohar; Kolykhalov, Alexander A.; Painter, George; Harcourt, Jennifer; Tamin, Azaibi; Thornburg, Natalie J.; Swanstrom, Ronald; Denison, Mark R.; Baric, Ralph S.;
    Published Date:
    April 06 2020
    Source:
    Sci Transl Med. 2020; 12(541)
    Description:
    Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2, the causative agent of COVID-19. Here, we show that the ribonucleoside analog β-d-N|-hydroxycyti...
    File Type:
    Filetype[PDF - 511.02 KB]
  4. Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity
    Personal Author:
    Yates, Mary K.; Chatterjee, Payel; Flint, Mike; Arefeayne, Yafet; Makuc, Damjan; Plavec, Janez; Spiropoulou, Christina F.; Seley-Radtke, Katherine L.;
    Published Date:
    September 02 2019
    Source:
    Molecules. 2019; 24(17)
    Description:
    Due to their ability to inhibit viral DNA or RNA replication, nucleoside analogues have been used for decades as potent antiviral therapeutics. However, one of the major limitations of nucleoside analogues is the development of antiviral resistance. ...
    File Type:
    Filetype[PDF - 2.34 MB]
  5. Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection
    Personal Author:
    Scholte, Florine E. M.; Hua, Brian L.; Spengler, Jessica R.; Dzimianski, John V.; Coleman-McCray, JoAnn D.; Welch, Stephen R.; McMullan, Laura K.; Nichol, Stuart T.; Pegan, Scott D.; Spiropoulou, Christina F.; Bergeron, Éric;
    Published Date:
    July 23 2019
    Source:
    mBio. 10(4)
    Description:
    Crimean-Congo hemorrhagic fever virus (CCHFV) infection can result in a severe hemorrhagic syndrome for which there are no antiviral interventions available to date. Certain RNA viruses, such as CCHFV, encode cysteine proteases of the ovarian tumor (...
    File Type:
    Filetype[PDF - 1.58 MB]